Dr. Oliver W. Press died September 29, 2017.  His obituary appears on the Fred Hutch web site. 

Memorial gifts may be made to the Oliver W. Press ARCS Foundation Endowed Fellowship (“The Ollie”), the Oliver “Ollie” W. Press Award for Extraordinary Mentorship, or the Oliver Press Memorial Clinical Trial Fund


Honors in the last years of life and posthumously: 

Oliver Press and Nancy Ottman Press received the Lymphoma Research Foundation Distinguished Service Award in New York on September 27, 2017

Oliver Press posthumously received the John Ultmann Award for Contributions to Lymphoma Research in New York on October 28, 2017. Watch the video of the award ceremony with Morton Coleman, MD; David Maloney, MD PhD; Ruth Ultmann; Michael F. Press, MD, PhD; and Nancy Ottman Press. 

Oliiver Press posthumously received the American Society of Hematology Mentor Award in Atlanta on December 10, 2017.  See the ASH announcement.

Dr. Oliver Press honored as first Giuliani/Press Endowed Chair

Dr. Oliver Press honored with 2017 Dr. Ali Al-Johani Award

Dr. Oliver Press named 2017 Leader in Health Care by Seattle Business Magazine

Dr. Oliver Press portrait unveiled, mentorship award announced

UW establishes Dr. Oliver W. Press Distinguished MSTP Alumnus Award - Video interview with Oliver W. Press MD PhD and Nancy Ottman Press MA MLibr

Lymphoma Research Foundation established the Oliver Press Postdoctoral Fellowship Grant 

Obituaries published:

Stanford University, "Dedicated Researcher, Physician and Mentor" 

American Association for Cancer Research, "In Memoriam: Oliver W. Press, MD, PhD"

American Society for Clinical Oncology, "Leading Lymphoma Clinician, Researcher, and Mentor, Oliver "Ollie" Press, MD, Phd, Dies at 65," and "ASCO Remembers Dr. Oliver Press"

Clinical Advances in Hematology & Oncology, "In Memory of Oliver Press, MD, PhD"

University of Washington Department of Medicine, "Remembering Ollie Press

The Hematologist, "Oliver W. Press, MD, PhD (1952-2017)"

Lymphoma Research Foundation, "Passing of Dr. Oliver Press

 

The Press Lab at the Fred Hutchinson Cancer Research Center is devoted to the investigation of novel treatments for hematologic malignancies including non-Hodgkin's lymphoma, leukemia, and myeloma. We conduct basic laboratory investigations using leukemia and lymphoma cell lines and mouse xenograft models as well as human clinical trials. Agents currently under investigation include monoclonal antibodies, radioimmunoconjugates, immunotoxins, chemotherapeutic agents, and genetically modified cytotoxic T lymphocytes. In the clinical arena, we are continuing our successful program of high dose radioimmunotherapy with stem cell transplantation for B cell lymphomas and have trials planned investigating pretargeted radioimmunotherapy and gene therapy using adoptively transferred cytotoxic T lymphocytes bearing chimeric anti-CD20 receptors.